Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1/2 trial

Journal:

Nature Medicine

Published:

2025-09-16

DOI:

10.1038/s41591-025-03919-w

Affiliations:

5

Authors:

7

Go to article

Institutions	Authors	Share
Rowan University, United States of America (USA)	2.333333	0.33
Myrtelle Inc., United States of America (USA)	2.000000	0.29
University of Cincinnati (UC), United States of America (USA)	1.000000	0.14
Wright State University, United States of America (USA)	0.833333	0.12
Dayton Children's Hospital, United States of America (USA)	0.833333	0.12

Interested in Medical Biotechnology?